{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:12:53Z","timestamp":1790917973184,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.081","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T22:20:47Z","timestamp":1302906047000},"page":"3982-3989","source":"Crossref","is-referenced-by-count":33,"title":["Th17\/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age"],"prefix":"10.1016","volume":"29","author":[{"given":"Petra","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Selak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Luhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Magyarics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reinisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lingnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Grubeck-Loebenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.03.081_bib0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2003.09.027","article-title":"Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults","volume":"22","author":"Fedson","year":"2004","journal-title":"Vaccine"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.03.081_bib0010","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1183\/09031936.00171309","article-title":"Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly","volume":"36","author":"Dominguez","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2011.03.081_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-10-73","article-title":"Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older","volume":"10","author":"Vila-Corcoles","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.03.081_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"March\u2013April (9465)","key":"10.1016\/j.vaccine.2011.03.081_bib0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.03.081_bib0040","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine vs. 23-valent polysaccharide vaccine in adults aged 50\u201380 years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.03.081_bib0045","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/IAI.67.9.4935-4938.1999","article-title":"Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination","volume":"67","author":"Lottenbach","year":"1999","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.03.081_bib0050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/infdis\/173.4.1014","article-title":"Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults","volume":"173","author":"Powers","year":"1996","journal-title":"J Infect Dis"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.03.081_bib0055","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0060","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0070","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/IAI.01199-09","article-title":"The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis","volume":"78","author":"Daniels","year":"2010","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0075","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/CVI.00395-08","article-title":"Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice","volume":"16","author":"Ferreira","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0080","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/IAI.72.5.2659-2670.2004","article-title":"Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins","volume":"72","author":"Hamel","year":"2004","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/IAI.01103-06","article-title":"Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae","volume":"75","author":"Ogunniyi","year":"2007","journal-title":"Infect Immun"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2006.07.028","article-title":"Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection","volume":"25","author":"Linder","year":"2007","journal-title":"Vaccine"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20011576","article-title":"The immune response to pneumococcal proteins during experimental human carriage","volume":"195","author":"McCool","year":"2002","journal-title":"J Exp Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.03.081_bib0100","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/315822","article-title":"Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media","volume":"182","author":"Rapola","year":"2000","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006454-200002000-00011","article-title":"Human antibodies to pneumococcal surface protein A in health and disease","volume":"19","author":"Virolainen","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.03.081_bib0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/319246","article-title":"Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children","volume":"183","author":"Simell","year":"2001","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.03.081_bib0115","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/IAI.70.10.5363-5369.2002","article-title":"Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children","volume":"70","author":"Zhang","year":"2002","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.inf.0000261198.90649.04","article-title":"Serum antibodies to the pneumococcal surface proteins PhtB and PhtE in Finnish infants and adults","volume":"26","author":"Holmlund","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.03.081_bib0125","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J Infect Dis"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2011.03.081_bib0130","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2007.01.065","article-title":"Vaccines in the era of genomics: the pneumococcal challenge","volume":"25","author":"Barocchi","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.081_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"Giefing","year":"2008","journal-title":"J Exp Med"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.03.081_bib0145","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1128\/JB.01505-08","article-title":"Influences of capsule on cell shape and chain formation of wild-type and PcsB mutants of serotype 2 Streptococcus pneumoniae","volume":"191","author":"Barendt","year":"2009","journal-title":"J Bacteriol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.03.081_bib0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2958.2004.04196.x","article-title":"Defective cell wall synthesis in Streptococcus pneumoniae R6 depleted for the essential PcsB putative murein hydrolase or the VicR (YycF) response regulator","volume":"53","author":"Ng","year":"2004","journal-title":"Mol Microbiol"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-1097(03)00167-8","article-title":"Functional analysis of a PcsB-deficient mutant of group B streptococcus","volume":"221","author":"Reinscheid","year":"2003","journal-title":"FEMS Microbiol Lett"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0160","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1742-4658.2005.04560.x","article-title":"Characterization of a eukaryotic type serine\/threonine protein kinase and protein phosphatase of Streptococcus pneumoniae and identification of kinase substrates","volume":"272","author":"Novakova","year":"2005","journal-title":"FEBS J"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2007.01.184","article-title":"A eukaryotic-type serine\/threonine protein kinase StkP of Streptococcus pneumoniae acts as a dimer in vivo","volume":"355","author":"Pallova","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.03.081_bib0170","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/JB.01616-06","article-title":"Eukaryotic-type serine\/threonine protein kinase StkP is a global regulator of gene expression in Streptococcus pneumoniae","volume":"189","author":"Saskova","year":"2007","journal-title":"J Bacteriol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2011.03.081_bib0175","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/mic.0.036335-0","article-title":"The pneumococcal eukaryotic-type serine\/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro","volume":"156","author":"Giefing","year":"2010","journal-title":"Microbiology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0180","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1128\/IAI.73.2.1006-1013.2005","article-title":"Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage","volume":"73","author":"Palaniappan","year":"2005","journal-title":"Infect Immun"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2011.03.081_bib0185","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.03.081_bib0190","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.00141-08","article-title":"Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells","volume":"76","author":"Trzcinski","year":"2008","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.081_bib0195","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.03.081_bib0200","first-page":"1899","article-title":"Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Invest"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.03.081_bib0205","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/IAI.00773-07","article-title":"Antibody-independent CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins","volume":"75","author":"Basset","year":"2007","journal-title":"Infect Immun"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","volume":"8","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coi.2005.07.002","article-title":"B cell development and receptor diversity during aging","volume":"17","author":"Allman","year":"2005","journal-title":"Curr Opin Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.smim.2005.05.005","article-title":"Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans","volume":"17","author":"Frasca","year":"2005","journal-title":"Semin Immunol"},{"issue":"Spring (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/rej.2006.9.117","article-title":"Antibody quality in old age","volume":"9","author":"Howard","year":"2006","journal-title":"Rejuvenation Res"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.03.081_bib0230","doi-asserted-by":"crossref","first-page":"B304","DOI":"10.1093\/gerona\/57.8.B304","article-title":"Altered memory B-cell homeostasis in human aging","volume":"57","author":"Breitbart","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonization: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"December (Suppl S2)","key":"10.1016\/j.vaccine.2011.03.081_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkf506","article-title":"Dynamics of nasopharyngeal colonization by potential respiratory pathogens","volume":"50","author":"Garcia-Rodriguez","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.03.081_bib0245","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/605023","article-title":"T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease","volume":"200","author":"Mureithi","year":"2009","journal-title":"J Infect Dis"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.03.081_bib0250","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/512617","article-title":"Low CD4T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children","volume":"195","author":"Zhang","year":"2007","journal-title":"J Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.03.081_bib0255","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1128\/IAI.00165-06","article-title":"Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children","volume":"74","author":"Zhang","year":"2006","journal-title":"Infect Immun"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/infdis\/170.1.110","article-title":"Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection","volume":"170","author":"Ericsson","year":"1994","journal-title":"J Infect Dis"},{"issue":"May (25)","key":"10.1016\/j.vaccine.2011.03.081_bib0265","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.03.081_bib0270","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.03.081_bib0275","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.180.12.7948","article-title":"Regulation of IL-17 in human CCR6+ effector memory T cells","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.03.081_bib0280","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/intimm\/dxn106","article-title":"The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation","volume":"20","author":"Annunziato","year":"2008","journal-title":"Int Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.03.081_bib0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0290","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yexmp.2005.11.004","article-title":"Inflammation markers predicting frailty and mortality in the elderly","volume":"80","author":"De Martinis","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.vaccine.2011.03.081_bib0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.03.081_bib0300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech Ageing Dev"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.03.081_bib0305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.imbio.2009.12.004","article-title":"The immunizing effect of pneumococcal nasopharyngeal colonization; protection against future colonization and fatal invasive disease","volume":"215","author":"Richards","year":"2010","journal-title":"Immunobiology"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2011.03.081_bib0310","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.0708426104","article-title":"Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes","volume":"104","author":"Evans","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.03.081_bib0315","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00109-009-0579-4","article-title":"Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development","volume":"88","author":"Malley","year":"2010","journal-title":"J Mol Med"},{"issue":"November (47\u201348)","key":"10.1016\/j.vaccine.2011.03.081_bib0320","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.081_bib0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4933-4-9","article-title":"Challenges for vaccination in the elderly","volume":"4","author":"Aspinall","year":"2007","journal-title":"Immun Ageing"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.03.081_bib0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin Exp Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T09:26:12Z","timestamp":1592472372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11004634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":66,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11004634"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}